Citation Tools
Clinical/translational cancer immunotherapy
Original research
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146